Evidence map›Paper›PMID 41403734›Full record

ArticleAdvanced pharmaceutical bulletin2025

Evaluating the Efficacy of a Semi-Solid Formulation with Clove Oil and Curcumin versus Clindamycin in the Treatment of Acne Vulgaris: A Comprehensive Study of Preclinical and Clinical Findings.

Peymaneh Dastgir, Setareh Tehrani, Setareh Haghighat, Sepideh Arbabi Bidgoli, Solmaz Ghaffari

Abstract read
In one paragraph

Article in Advanced pharmaceutical bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Peymaneh DastgirPharmaceutical Sciences Research Center, TeMS.C., Islamic Azad University, Tehran, Iran.ORCID https://orcid.org/0009-0001-2648-0976
Setareh TehraniChair of the Department of Dermatology, TeMS.C., Islamic Azad University, Tehran, Iran.ORCID https://orcid.org/0000-0002-6197-4461
Setareh HaghighatDepartment of Microbiology, TeMS.C., Islamic Azad University, Tehran, Iran.ORCID https://orcid.org/0000-0002-6605-5245
Sepideh Arbabi BidgoliDepartment of Toxicology and Pharmacology, TeMS.C., Islamic Azad University, Tehran, Iran.ORCID https://orcid.org/0000-0003-4830-8680
Solmaz GhaffariDepartment of Pharmaceutics, TeMS.C., Islamic Azad University, Tehran, Iran.ORCID https://orcid.org/0000-0002-5166-5112

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Acne vulgaris is a chronic inflammatory condition affecting the pilosebaceous units. With the rise of antibiotic resistance and the potential side effects associated with conventional treatments, there is increasing interest in exploring natural alternatives for treating acne. This study aimed to formulate and clinically evaluate a topical gel containing clove oil and curcumin in patients with mild to moderate acne vulgaris, using topical clindamycin as a standard comparator. Methods: The antibacterial activity of clove oil and curcumin against Results: The clove oil-curcumin gel demonstrated comparable efficacy to clindamycin in reducing acne lesions, papules, and ASI. While no significant differences were observed between the two groups in comedone reduction, patient satisfaction increased in clove oil-curcumin gel group. Conclusion: Topical application of a gel containing clove oil and curcumin demonstrated promising results as an effective and well-tolerated alternative or adjunctive therapy for acne vulgaris. These findings support the potential of plant-based formulations in acne management.

Indexed as

Acne vulgarisClindamycinClinical studyNatural ingredientsSemi-solid formulationSide effects

Identifiers

PMID41403734
PMCPMC12703380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.